Russell Frank Company’s Albany Molecular Research Inc AMRI Stock Holding History

Russell Frank Company’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$3.98M	Sell	260,479 -120,481	-32%	-$1.89M	0.01%	1473
2015 Q4	$7.81M	Sell	380,960 -21,973	-5%	-$418K	0.01%	1021
2015 Q3	$7.02M	Sell	402,933 -80,268	-17%	-$1.63M	0.01%	1079
2015 Q2	$9.77M	Buy	483,201 +142,616	+42%	+$2.75M	0.02%	1000
2015 Q1	$5.99M	Sell	340,585 -69,183	-17%	-$1.18M	0.01%	1138
2014 Q4	$6.5M	Sell	409,768 -152,147	-27%	-$2.79M	0.01%	1130
2014 Q3	$12.4M	Sell	561,915 -4,298	-0.8%	-$88K	0.02%	796
2014 Q2	$11.4M	Buy	566,213 +83,961	+17%	+$1.42M	0.02%	831
2014 Q1	$7.73M	Buy	482,252 +287,095	+147%	+$3.95M	0.01%	1028
2013 Q4	$2.11M	Sell	195,157 -142,275	-42%	-$1.72M	﹤0.01%	1690
2013 Q3	$4.35M	Sell	337,432 -89,174	-21%	-$1.1M	0.01%	1414
2013 Q2	$5.06M	Buy	+426,606	New	+$4.62M	0.01%	1224

Other funds holding AMRI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Russell Frank Company's AMRI Position: Q1 2016 in Review

Russell Frank Company reduced its Albany Molecular Research Inc (AMRI) stake by 32% in Q1 2016, selling an estimated $1.89M and leaving 260,479 shares worth $3.98M. The position accounts for 0.01% of the portfolio, ranked #1473.

Russell Frank Company first reported a position in AMRI in Q2 2013 and has held it in 12 quarters since. The position peaked at $12.4M in Q3 2014. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

Russell Frank Company held 260,479 shares of Albany Molecular Research Inc worth $3.98M as of Q1 2016.
Russell Frank Company sold 120,481 Albany Molecular Research Inc shares in Q1 2016, an estimated $1.89M.
Albany Molecular Research Inc made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1473 holding.
Russell Frank Company first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Albany Molecular Research Inc position peaked at $12.4M in Q3 2014.
141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.